Primary Analysis of the SYMPATICO trial in Mantle Cell Lymphoma
Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.
Lori Leslie Jamesk Mccloskey Gloria Leslie Hackensack University Medical Center John Theurer Cancer Center Research Programs
Source: onclive.com